Related Experiment Video
Updated: Oct 8, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Can NAFLD overwhelm the Spanish healthcare system in the years to come?
Javier Crespo1, Paula Iruzubieta2, Jeffrey V Lazarus3
1Aparato Digestivo, Hospital Universitario Marqués de Valdecilla, 39002.
Abstract:
Non-alcoholic fatty liver disease (NAFLD) is the leading driver of chronic liver disease globally and is likely to become the main cause of end-stage liver disease and liver transplantation in the next decades. In a 2021 global study of the preparedness of 102 countries to address NAFLD, Spain scored ninth overall and seventh in Europe. Although, no country scored over 50/100. Other countries in Europe, including neighboring ones such as Italy, France and Portugal scored 7.77, 6.21 and 0.5, respectively, in their readiness to address NAFLD. Although, Spain is better prepared to battle this pandemic, there is still much work to be done to be able to tackle this highly prevalent, costly and often mortal condition by further identifying NAFLD preparedness gaps and addressing those already known.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Atherosclerosis IV: Nursing Management
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Collaborative Care
Assessment:
